News tagged with biotechnology company
Elan enters $1B royalty deal with Theravance
Irish drugmaker Elan Corp. PLC plans to pay $1 billion for the right to future royalties from four respiratory treatments being developed by Theravance Inc. and GlaxoSmithKline.
Medications
May 13, 2013 |
not rated yet |
0
Sanofi earnings slashed in first quarter
(AP)—French drug maker Sanofi said Thursday its net profit was slashed in the first quarter from a year earlier as falling sales and patent losses on key drugs combined to hammer earnings.
Other
May 02, 2013 |
not rated yet |
0
US top court to hear case on gene patents
The US Supreme Court will hear arguments Monday on whether to allow private entities to patent genes they have isolated and identified, a decision that could have far-reaching implications for genetic research.
Genetics
Apr 13, 2013 |
5 / 5 (2) |
0
Engineering and autism: Chemical engineer investigates autism spectrum disorders
(Medical Xpress)—The University of Delaware's Prasad Dhurjati is a chemical engineer whose background includes systems engineering, biotechnology and artificial intelligence. Yet recently, he has been investigating autism ...
Autism spectrum disorders
Mar 05, 2013 |
2 / 5 (2) |
2
25 new autism-related gene variants discovered
Genetics researchers have identified 25 additional copy number variations (CNVs)—missing or duplicated stretches of DNA—that occur in some patients with autism. These CNVs, say the researchers, are "high impact": although ...
Genetics
Jan 14, 2013 |
4.3 / 5 (3) |
0
|
Researchers develop milk that protects against HIV
Melbourne researchers have developed cows' milk that protects human cells from HIV.
HIV & AIDS
Oct 17, 2012 |
not rated yet |
0
Research gives new insight into coeliac disease
For the first time, scientists have visualised an interaction between gluten and T-cells of the immune system, providing insight into how coeliac disease, which affects approximately 1 in 133 people, is triggered.
Immunology
Oct 11, 2012 |
5 / 5 (2) |
0
|
Biological markers increase clinical trial success rate of new breast cancer drugs
Using biological markers—genetic characteristics that are associated with some patients with breast cancer—can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research ...
Cancer
Oct 01, 2012 |
not rated yet |
0
Experimental drug may extend therapeutic window for stroke
A team led by a physician-scientist at the University of Southern California (USC) has created an experimental drug that reduces brain damage and improves motor skills among stroke-afflicted rodents when given with federally ...
Cardiology
Jul 17, 2012 |
not rated yet |
0
Georgetown University Medical Center licenses 'theranostic' for development
Georgetown University Medical Center (GUMC) has licensed worldwide rights of a potential novel cancer therapy and diagnostic, or "theranostic," to BioMetrx, LLC. The agent was invented by two Georgetown researchers.
Cancer
Jan 24, 2012 |
not rated yet |
0
Universal flu vaccine clinical trials show promise
A universal influenza vaccine targeting a protein common to all strains of influenza A has safely produced an immune response in humans. If proven effective, the vaccine could eliminate the practice of creating a new flu ...
Medications
Jun 07, 2011 |
5 / 5 (3) |
0
|
